Trial
NCT05829460
Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
Novo Nordisk A/S
Condition
Endometrial Hyperplasia
Intervention
Semaglutide
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-12